
MIRA Valuation
Mira Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
MIRA Relative Valuation
MIRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MIRA is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
18.84
P/B
Median3y
11.47
Median5y
11.47
-25.72
FCF Yield
Median3y
-24.68
Median5y
-24.68
Competitors Valuation Multiple
The average P/S ratio for MIRA's competitors is 30.24, providing a benchmark for relative valuation. Mira Pharmaceuticals Inc Corp (MIRA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

AAPL
Apple Inc
199.930
USD
+2.39%

MSFT
Microsoft Corp
458.680
USD
+1.89%

META
Meta Platforms Inc
641.300
USD
+2.27%

NVDA
NVIDIA Corp
135.335
USD
+3.08%

TSLA
Tesla Inc
359.870
USD
+6.05%

XOM
Exxon Mobil Corp
103.410
USD
+0.37%

AMZN
Amazon.com Inc
206.300
USD
+2.64%

WMT
Walmart Inc
97.315
USD
+1.01%

ORCL
Oracle Corp
162.075
USD
+3.91%

AVGO
Broadcom Inc
235.530
USD
+2.98%
FAQ

Is Mira Pharmaceuticals Inc (MIRA) currently overvalued or undervalued?
Mira Pharmaceuticals Inc (MIRA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Mira Pharmaceuticals Inc (MIRA) is between to according to relative valuation methord.

What is Mira Pharmaceuticals Inc (MIRA) fair value?

How does MIRA's valuation metrics compare to the industry average?

What is the current P/B ratio for Mira Pharmaceuticals Inc (MIRA) as of May 27 2025?

What is the current FCF Yield for Mira Pharmaceuticals Inc (MIRA) as of May 27 2025?

What is the current Forward P/E ratio for Mira Pharmaceuticals Inc (MIRA) as of May 27 2025?
